Table:
begin	end	state
1	1632	non-cytoplasmic

Input:
>PfGW456L13_3298
MAFFTAASKADFQHQLQAALAQHISEQALPQVALFSEQFFGIISLDELTQRRLSDLAGCT
LSAWRMLERFDHAQPQVRVYNPDYERHGWQSTHTAVEVLHHDLPFLVDSVRTELNRRGYS
IHTLQTTVLSVRRGSKGELLEILPKGTQGDDIQQESLMYLEIDRCANTAELNVLSKELEQ
VLGEVRVAVGDFEPMKAKVQDILTKLDNSQFAVDGDEKNEIKSFLEWLVGNHFTFLGYEE
FVVSDEADGGHIVYDKDSFLGLTKLLRAGLTYDDLRIEDYAVNYLREPTLLSFAKAAHPS
RVHRPAYPDYVSIREIDADGKVIKECRFMGLYTSSVYGESVRVIPYIRRKVEEIERRSGF
QAKAHLGKELAQVLEVLPRDDLFQTPVDELFSTVMSIVQIQERNKIRVFLRKDPYGRFCY
CLAYVPRDIYSTEVRQKIQQVLMDRLKASDCEFWTFFSESVLARVQLILRVDPKNRLDID
PLLLEKEVVQACRSWQDDYAALTVESFGEAHGTNVLADFPKGFPAGYRERFAAHSAVVDM
QHLLSLNEKNPLVMSFYQPLGQVSGQRMLHCKLYHADTPLALSDVLPILENLGLRVLGEF
PYRLRHNSGREFWIHDFAFTAAEGLELDIQQLNDTLQDAFVHIVRGDAENDGFNRLVLTA
GLPWRDVALLRAYARYMKQIRLGFDLGYIASTLNNHTDIAHELTRLFKTRFYLARKLTGE
DLGDKQQRLEHAILSALDDVQVLNEDRILRRYLDLIKATLRTNFYQTDANGHNKSYFSFK
FNPHLIPELPKPVPKFEIFVYSPRVEGVHLRFGNVARGGLRWSDREEDFRTEVLGLVKAQ
QVKNSVIVPVGAKGGFLPRRLPLGGSRDEIAAEGIACYRIFISGLLDITDNLKDGALVPP
ANVVRHDDDDPYLVVAADKGTATFSDIANGIAIDYGFWLGDAFASGGSAGYDHKKMGITA
KGAWVGVQRHFRERGINVQEDSITVVGVGDMAGDVFGNGLLMSDKLQLVAAFNHLHIFID
PNPEPASSFAERQRLFDLPRSAWSDYDTSLMSEGGGIFSRSAKSIAISPQMQERFDIQAD
KLTPTELLNALLKAPVDLLWNGGIGTYVKASSESHADVGDKANDALRVNGNELRCKVVGE
GGNLGMTQLGRVEFGLNGGGSNTDFIDNAGGVDCSDHEVNIKILLNEVVQAGDMTDKQRN
ELLASMTDEVGGLVLGNNYKQTQALSLAARRALPRIAEYKRLMNDLEGRGKLDRAIEFLP
AEEAINERIAEGHGLTRAELSVLISYSKIDLKEQLLGSLVPDDDYLTRDMETAFPPTLVS
KFSAAMRRHRLKREIVSTQIANDLVNHMGITFVQRLKESTGMSPANVAGAYVIVRDIFHL
PHWFRQIENLDYKVSADVQLELMDELMRLGRRATRWFLRARRNEQNAARDVAHFGPHLAA
LGLKLDELLSGEIRETWQTRYQAYVEAGVPELLARMVAGTTHLYTLLPIIEASDVTGQDP
ADVAKAYFAVGSALDITWYLQQISALPVENNWQALAREAFRDDVDWQQRAITISVLQQGD
GSQEVETRLDLWMQQHESMIERWRAMLVEIRAASGTDYAMYAVANRELLDLALSGQAVVP
AAVAAAELEPAA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server